Mark your calendar – March 25 for the start of the Educational Approach Pilot in support of Vanessa’s Law

CSHP is keen to participate in the Educational Approach Pilot designed to provide educational material to help implement The Protecting Canadians from Unsafe Drugs Act. Vanessa’s Law, as the Act is also known, includes a regulatory provision for mandatory reporting by hospitals of serious adverse drug reactions and medical device incidents. This requirement is expected to come into force later this year.

Everyone is welcome to participate in the pilot, which is scheduled to begin on March 25 and continue for 2 weeks. Interested persons should anticipate that the review of the educational materials will take about 2 to 3 hours to complete. CSHP will provide the links to the educational materials and feedback questionnaire.

The educational materials (provided in PowerPoint slides) were designed for use by patients and their families, hospitals, professional organizations, educators, and accrediting bodies to raise awareness of the regulations and provide supporting information. They were developed through a joint venture of the Institute for Safe Medication Practices Canada (ISMP Canada), Health Standards Organization (HSO) and the Canadian Patient Safety Institute (CPSI) to help Health Canada with outreach, education, and feedback regarding the mandatory reporting of serious adverse drug reactions and medical device incidents.

Interested in learning more about the mandatory reporting requirement and missed the presentation by Rhonda Kropp (Director General, Marketed Health Products Directorate, Health Canada), Mandatory Reporting of Adverse Reactions for Hospitals: Your Role in Patient Safety, at CSHP’s Professional Practice Conference last month? Click here to view the presentation.